In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evofem Biosciences Inc.

www.evofem.com

Latest From Evofem Biosciences Inc.

Evofem Plans 2019 Refiling For Amphora Based On New 86% Contraception Efficacy

Evofem intends to refile the NDA for its non-hormonal contraceptive Amphora during the second quarter of 2019, after the Phase III AMPOWER study showed 86% efficacy for typical use and 98.7% efficacy when the gel was used as directed.

Business Strategies Clinical Trials

Finance Watch: Six More IPO Filings As Three More Biopharmas Go Public In The US

Public Company Edition: Kiniksa, Scholar Rock and Iterum launch the most recent US IPOs and at least five more drug developers join the queue. Also, Polyphor go public in Switzerland, Valeant and Ligand sell notes, and MyoKardia led recent follow-on offerings.

Financing Business Strategies

Deals Shaping The Medical Industry, November 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2017.

Deals BioPharmaceutical

Deal Watch: Neos Says ‘Thanks, No Thanks’ To Repeated PDL Offer

Daiichi teams with Glycotope on an antibody-drug conjugate for cancer, while Alector will partner with AbbVie to research antibody targets for Alzheimer’s disease.

Deals M & A
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Alias(es)
  • Instead Healthcare Inc.
  • Evofem Holdings Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Evofem Biosciences Inc.
  • Senior Management
  • Saundra Pelletier, CEO
    Jay File, CFO
    Kelly Culwell, MD, CMO
    Russ Barrons, Chief Commercial Officer
    Tim Glennon, VP, Sales & Mktg.
    Catherine Maher, VP, Reg. Affairs & Quality Assurance
  • Contact Info
  • Evofem Biosciences Inc.
    Phone: (858) 550-1901
    12400 High Bluff Dr.
    Ste. 600
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register